Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-06

Clinical Trial Update: Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4 [Phase 2]

View source ↗

Summary

Phase 2 trial update on co-administration of AS03 adjuvanted A/H7N9 inactivated influenza vaccine with a standard influenza vaccine (IIV4) completed with posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AS03 adjuvanted A/H7N9 inactivated influenza vaccine (AS03-adjuvanted A/H7N9 IIV)
  • IIV4 (inactivated influenza vaccine for quadrivalent formulation)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Avian Influenza, Influenza | Phase 2 | Status: COMPLETED | Results posted: 2020-08-06